Bone morphogenetic protein 2 and activin A synergistically stimulate follicle-stimulating hormone β subunit transcription

Journal of Molecular Endocrinology

Volumn 38, Issue 1-2, 2007, Pages 315-330

  Lee, Katharine B ^a   Khivansara, Vishal ^b   Santos, Michelle M ^b   Lamba, Pankaj ^a,b   Yuen, Tony ^c   Sealfon, Stuart C ^c   Bernard, Daniel J ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b ROCKEFELLER UNIVERSITY   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; ACTIVIN RECEPTOR 2; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 6; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; FOLLITROPIN BETA SUBUNIT; MESSENGER RNA; MYELOPID; OSTEOGENIC PROTEIN 1; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HORMONAL REGULATION; HORMONE SYNTHESIS; HYPOPHYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION;

ACTIVINS; ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL LINE, TRANSFORMED; FOLLICLE STIMULATING HORMONE, BETA SUBUNIT; GENE EXPRESSION REGULATION; HUMANS; MICE; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 33847656978     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.1.02196     Document Type: Article

References (69)

1. Abe Y, Abe T, Aida Y, Hara Y & Maeda K 2004 Follistatin restricts bone morphogenetic protein (BMP)-2 action on the differentiation of osteoblasts in fetal rat mandibular cells. Journal of Bone and Mineral Research 19 1302-1307.
2. Allendorph GP, Vale WW & Choe S 2006 Structure of the ternary signaling complex of a TGF-beta superfamily member. PNAS 103 7643-7648.
3. Aoki H, Fujii M, Imamura T, Yagi K, Takehara K, Kato M & Miyazono K 2001 Synergistic effects of different bone morphogenetic protein type I receptors on alkaline phosphatase induction. Journal of Cell Science 114 1483-1489.
4. Bailey JS, Rave-Harel N, McGillivray SM, Coss D & Mellon PL 2004 Activin regulation of the follicle-stimulating hormone beta-subunit gene involves Smads and the TALE homeodomain proteins Pbx1 and Prep1. Molecular Endocrinology 18 1158-1170.
5. Bernard DJ 2004 Both SMAD2 and SMAD3 mediate activin-stimulated expression of the follicle-stimulating hormone beta subunit in mouse gonadotrope cells. Molecular Endocrinolgy 18 606-623.
6. Besecke LM, Guendner MJ, Sluss PA, Polak AG, Woodruff TK, Jameson JL, Bauer-Dantoin AC & Weiss J 1997 Pituitary follistatin regulates activin-mediated production of follicle-stimulating hormone during the rat estrous cycle. Endocrinology 138 2841-2848.
7. Candia AF, Watabe T, Hawley SH, Onichtchouk D, Zhang Y, Derynck R, Niehrs C & Cho KW 1997 Cellular interpretation of multiple TGF-beta signals: intracellular antagonism between activin/BVg1 and BMP-2/4 signaling mediated by Smads. Development 124 4467-4480.
8. Chapman SC, Bernard DJ, Jelen J & Woodruff TK 2002 Properties of inhibin binding to betaglycan, InhBP/p120 and the activin type II receptors. Molecular and Cellular Endocrinology 196 79-93.
9. Chen YG & Massague J 1999 Smadl recognition and activation by the ALK1 group of transforming growth factor-beta family receptors. Journal of Biological Chemistry 274 3672-3677.
10. Chen Y, Bhushan A & Vale W 1997 Smad8 mediates the signaling of the ALK-2 (corrected) receptor serine kinase. PNAS 94 12938-12943.
11. Chen D, Ji X, Harris MA, Feng JQ, Karsenty G, Celeste AJ, Rosen V, Mundy GR & Harris SE 1998 Differential roles for bone morphogenetic protein (BMP) receptor type IB and IA in differentiation and specification of mesenchymal precursor cells to osteoblast and adipocyte lineages. Journal of Cell Biology 142 295-305.
12. Cook RW, Thompson TB, Kurup SP, Jardetzky TS & Woodruff TK 2005 Structural basis for a functional antagonist in the transforming growth factor beta superfamily. Journal of Biological Chemistry 280 40177-40186.
13. Corrigan A-Z, Bilezikjian LM, Carroll RS, Bald LN, Schmelzer CH, Fendly, BM, Mason AJ, Chin WW, Schwall RH & Vale W 1991 Evidence for an autocrine role of activin B within rat anterior pituitary cultures. Endocrinology 128 1682-1684.
14. Dale L, Howes G, Price BM & Smith JC 1992 Bone morphogenetic protein 4: a ventralizing factor in early Xenopus development. Development 115 573-585.
15. Derynck R & Zhang YE 2003 Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425 577-584.
16. Dupont J, McNeilly J, Vaiman A, Canepa S, Combarnous Y & Taragnat C 2003 Activin signaling pathways in ovine pituitary and LbetaT2 gonadotrope cells. Biology of Reproduction 68 1877-1887.
17. Faure MO, Nicol L, Fabre S, Fontaine J, Mohoric N, McNeilly A & Taragnat C 2005 BMP-4 inhibits follicle-stimulating hormone secretion in ewe pituitary. Journal of Endocrinology 186 109-121.
18. Galloway SM, McNatty KP, Cambridge LM, Laitinen MP, Juengel JI., Jokiranta TS, McLaren RJ, Luiro K, Dodds KG, Montgomery GW et al. 2000 Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nature Genetics 25 279-283.
19. Gilboa L, Nohe A, Geissendorfer T, Sebald W, Henis YI & Knaus P 2000 Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors. Molecular Biology of the Cell 11 1023-1035.
20. Gore AJ, Philips DP, Miller WL & Bernard DJ 2005 Differential regulation of follicle stimulating hormone by activin A and TGFB1 in murine gonadotropes. Reproductive Biology and Endocrinology 3 73.
21. Gregory SJ, Lacza CT, Detz AA, Xu S, Petrillo LA & Kaiser UB 2005 Synergy between activin A and gonadotropin-releasing hormone in transcriptional activation of the rat follicle-stimulating hormone-beta gene. Molecular Endocrinology 19 237-254.
22. Harrison CA, Gray PC, Vale WW & Robertson DM 2005 Antagonists of activin signaling: mechanisms and potential biological applications. Trends in Endocrinology and Metabolism 16 73-78.
23. Hassel S, Schmitt S, Hartung A, Roth M, Nohe A, Petersen N, Ehrlich M, Henis YI, Sebald W & Knaus P 2003 Initiation of Smad-dependent and Smad-independent signaling via distinct BMP-receptor complexes. Journal of Bone and Joint Surgery. American Volume 85-A 44-51.
24. Hata A, Seoane J, Lagna G, Montalvo E, Hemmati-Brivanlou A & Massague J 2000 OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways. Cell 100 229-240.
25. He W, Dorn DC, Erdjument-Bromage H, Tempst P, Moore MA & Massague J 2006 Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. Cell 125 929-941.
26. Hoodless PA, Haerry T, Abdollah S, Stapleton M, O'Connor MB, Attisano L & Wrana JL 1996 MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 85 489-500.
27. Huang HJ, Sebastian J, Strahl BD, Wu JC & Miller WL 2001a The promoter for the ovine follicle-stimulating hormone-beta gene (FSHbeta) confers FSHbeta-like expression on luciferase in transgenic mice: regulatory studies in vivo and in vitro. Endocrinology 142 2260-2266.
28. Huang HJ, Sebastian J, Strahl BD, Wu JC & Miller WL 2001b Transcriptional regulation of the ovine follicle-stimulating hormone-beta gene by activin and gonadotropin-releasing hormone (GnRH): involvement of two proximal activator protein-1 sites for GnRH stimulation. Endocrinology 142 2267-2274.
29. Huang HJ, Wu JC, Su P, Zhirnov O & Miller WL 2001c A novel role for bone morphogenetic proteins in the synthesis of follicle-stimulating hormone. Endocrinology 142 2275-2283.
30. Inman GJ, Nicolas FJ, Callahan JF, Harling JD, Gaster LM, Reith AD, Laping NJ & Hill CS 2002 SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Molecular Pharmacology 62 65-74.
31. Israel DI, Nove J, Kerns KM, Kaufman RJ, Rosen V, Cox KA & Wozney JM 1996 Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo. Growth Factors 13 291-300.
32. Jaatinen R, Bondestam J, Raivio T, Hilden K, Dunkel L, Groome N & Ritvos O 2002 Activation of the bone morphogenetic protein signaling pathway induces inhibin β-subunit mRNA and secreted inhibin B levels in cultured human granulosa-luteal cells. Journal of Clinical Endocrinology and Metabolism 87 1254-1261.
33. Jacobs SB, Coss D, McGillivray SM & Mellon PL 2003 Nuclear factor Y and steroidogenic factor 1 physically and functionally interact to contribute to cell-specific expression of the mouse Follicle-stimulating hormone-beta gene. Molecular Endocrinology 17 1470-1483.
34. Jones CM, Lyons KM, Lapan PM, Wright CV & Hogan BL 1992 DVR-4 (bone morphogenetic protein-4) as a posterior-ventralizing factor in Xenopus mesoderm induction. Development 115 639-647.
35. Kearns AE & Demay MB 2000 BMP-2 induces the expression of activin betaA and follistatin in vitro. Journal of Cellular Biochemistry 79 80-88.
36. Kimura N, Matsuo R, Shibuya H, Nakashima K & Taga T 2000 BMP2-induced apoptosis is mediated by activation of the TAK1-p38 kinase pathway that is negatively regulated by Smad6. Journal of Biological Chemistry 275 17647-17652.
37. Lagna G, Hata A, Hemmati-Brivanlou A & Massague J 1996 Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways. Nature 383 832-836.
38. Lamba P, Santos MM, Philips DP & Bernard DJ 2006 Acute regulation of murine follicle-stimulating hormone beta subunit transcription by activin A. Journal of Molecular Endocrinology 36 201-220.
39. Lebrun JJ & Vale WW 1997 Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation. Molecular and Cellular Biology 17 1682-1691.
40. Levy L & Hill CS 2005 Smad4 dependency defines two classes of transforming growth factor β (TGF-β) target genes and distinguishes TGF-ß-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses. Molecular and Cellular Biology 25 8108-8125.
41. Lewis KA, Gray PC, Blount AL, MacConell LA, Wiater E, Bilezikjian LM & Vale W 2000 Betaglycan binds inhibin and can mediate functional antagonism of activin signalling. Nature 404 411-414.
42. Lui F, Ventura F, Doody J & Massague J 1995 Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs. Molecular and Cellular Biology 15 3479-3486.
43. Macias-Silva M, Hoodless PA, Tang SJ, Buchwald M & Wrana JL 1998 Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2. Journal of Biological Chemistry 273 25628-25636.
44. Miyazawa K, Shinozaki M, Hara T, Furuya T & Miyazono K 2002 Two major Smad pathways in TGF-beta superfamily signalling. Genes Cells 7 1191-1204.
45. Miyazono K 1999 Signal transduction by bone morphogenetic protein receptors: functional roles of Smad proteins. Bone 25 91-93.
46. Nohe A, Hassel S, Ehrlich M, Neubauer F, Sebald W, Henis YI & Knaus P 2002 The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. Journal of Biological Chemistry 277 5330-5338.
47. Nohe A, Keating E, Underhill TM, Knaus P & Petersen NO 2003 Effect of the distribution and clustering of the type I A BMP receptor (ALK-3) with the type II BMP receptor on tire activation of signalling pathways. Journal of Cell Science 116 3277-3284.
48. Otsuka F & Shimasaki S 2002 A novel function of bone morphogenetic protein-15 in the pituitary: selective synthesis and secretion of FSH by gonadotropes. Endocrinology 143 4938-4941.
49. Paez-Pereda M, Giacomini D, Refojo D, Nagashima AC, Hopfner U, Grubler Y, Chervin A, Goldberg V, Goya R, Hentges ST et al. 2003 Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk. PNAS 100 1034-1039.
50. Pardali K, Kowanetz M, Heldin CH & Moustakas A 2005 Smad pathway-specific transcriptional regulation of the cell cycle inhibitor p21 (WAF1/Cip1). Journal of Cellular Physiology 204 260-272.
51. Pernasetti F, Vasilyev, VV, Rosenberg SB, Bailey JS, Huang HJ, Miller WL & Mellon PL 2001 Cell-specific transcriptional regulation of follicle-stimulating hormone-beta by activin and gonadotropin-releasing hormone in the LbetaT2 pituitary gonadotrope cell model. Endocrinology 142 2284-2295.
52. Reguly T & Wrana JL 2003 In or out? The dynamics of Smad nucleocytoplasmic shuttling Trends in Cell Biology 13 216-220.
53. Rosenfeld MG, Briata P, Dasen J, Gleiberman AS, Kioussi C, Lin C, O'Connell SM, Ryan A, Szeto DP & Treier M 2000 Multistep signaling and transcriptional requirements for pituitary organo-genesis in vivo. Recent Progress in Hormone Research 55 1-13 (discussion 13-14).
54. Safwat N, Ninomiya-Tsuji J, Gore AJ & Miller WL 2005 Transforming growth factor beta-activated kinase 1 is a key mediator of ovine follicle-stimulating hormone beta-subunit expression. Endocrinology 146 4814-4824.
55. Sidis Y, Mukherjee A, Keutmann H, Delbaere A, Sadatsuki M & Schneyer A 2006 Biological activity of follistatin isoforms and follistatin like-3 are dependent on differential cell surface binding and specificity for activin, Myostatin and BMP's. Endocrinology 147 3586-3597.
56. Sugino H, Sugino K, Hashimoto O, Shoji H & Nakamura T 1997 Follistatin and its role as an activin-binding protein. Journal of Medical Investigation 44 1-14.
57. Suszko MI & Woodruff TK 2006 Cell-specificity of transforming growth factor-[beta] response is dictated by receptor bioavailability. Journal of Molecular Endocrinology 36 591-600.
58. Suszko MI, Lo DJ, Suh H, Camper SA & Woodruff TK 2003 Regulation of the rat follicle-stimulating hormone beta-subunit promoter by activin. Molecular Endocrinology 17 318-332.
59. Suszko MI, Balkin DM, Chen Y & Woodruff TK 2005 Smad3 mediates activin-induced transcription of follicle-stimulating hormone beta-subunit gene. Molecular Endocrinology 19 1849-1858.
60. Takeda M, Otsuka F, Suzuki J, Kishida M, Ogura T, Tamiya T & Makino H 2003 Involvement of activin/BMP system in development of human pituitary gonadotropinomas and nonfunctioning adenomas. Biochemical and Biophysical Research Communications 306 812-818.
61. ten Dijke P, Yamashita H, Sampath TK, Reddi AH, Estevez M, Riddle DL, Ichijo H, Heldin CH & Miyazono K 1994 Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. Journal of Biological Chemistry 269 16985-16988.
62. Thompson TB, Lerch TF, Cook RW, Woodruff TK & Jardetzky TS 2005 The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding. Developmental Cell 9 535-543.
63. West BE, Parker GE, Savage JJ, Kiratipranon P, Toomey KS, Beach LR, Colvin SC, Sloop KW & Rhodes SJ 2004 Regulation of the follicle-stimulating hormone beta gene by the LHX3 LIM-homeodomain transcription factor. Endocrinology 145 4866-4879.
64. Wiater E & Vale W 2003 Inhibin is an antagonist of bone morphogenetic protein signaling. Journal of Biological Chemistry 278 7934-7941.
65. Wiater E, Harrison CA, Lewis KA, Gray PC & Vale WW 2006 Identification of distinct inhibin and TGFbeta binding sites on betaglycan: functional separation of betaglycan co-receptor actions. Journal of Biological Chemistry 281 17011-17022.
66. Woodruff TK, Besecke LM, Groome N, Draper LB, Schwartz NB & Weiss J 1996 Inhibin A and inhibin B are inversely correlated to follicle-stimulating hormone, yet are discordant during the follicular phase of the rat estrous cycle, and inhibin A is expressed in a sexually dimorphic manner. Endocrinology 137 5463-5467.
67. Xiao L, Yuan X & Sharkis SJ 2006 Activin A maintains self-renewal and regulates FGF, Wnt and BMP pathways in human embryonic stem cells. Stem Cells 24 1476-1486.
68. Yuen T, Wurmbach E, Pfeffer RL, Ebersole BJ & Sealfon SC 2002 Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays. Nucleic Acids Research 30 e48.
69. Zou H, Wieser R, Massague J & Niswander L 1997 Distinct roles of type I bone morphogenetic protein receptors in the formation and differentiation of cartilage. Genes and Development 11 2191-2203.